S S Pierangeli, D E Ferrara. Show Affiliations »
Abstract
Entities: Chemical Gene
Mesh: See more » Antibodies, Antiphospholipid/physiologyAntiphospholipid Syndrome/drug therapyContraindicationsEndothelium, Vascular/chemistryFatty Acids, Monounsaturated/administration & dosageFatty Acids, Monounsaturated/pharmacologyFibrinolytic Agents/therapeutic useFluvastatinHumansHydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosageHydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacologyIndoles/administration & dosageIndoles/pharmacologyNF-kappa B/metabolismPyridines/administration & dosagePyridines/pharmacologySimvastatin/administration & dosageSimvastatin/pharmacologyThromboplastin/antagonists & inhibitorsThrombosisUp-Regulation/drug effects
Substances: See more » Antibodies, AntiphospholipidFatty Acids, MonounsaturatedFibrinolytic AgentsHydroxymethylglutaryl-CoA Reductase InhibitorsIndolesNF-kappa BPyridinesFluvastatinThromboplastinSimvastatincerivastatin
Year: 2005 PMID: 15869627 DOI: 10.1111/j.1538-7836.2005.01262.x
Source DB: PubMed Journal: J Thromb Haemost ISSN: 1538-7836 Impact factor: 5.824